Evaluation and Management of Precocious Puberty

Introduction to Precocious Puberty

The American Academy of Pediatrics recommends documenting the precise age when secondary sexual characteristics first appeared, as onset before age 8 in girls or age 9 in boys defines precocious puberty and warrants endocrine evaluation 1
The Endocrine Society suggests assessing the rate of progression of pubertal changes, including breast development, pubic hair, and menarche in girls, to determine the need for urgent intervention 1
The American College of Obstetricians and Gynecologists recommends specifically asking about menarche timing in girls age 9 years, determining whether other pubertal signs are present and their progression timeline, as isolated menarche may represent a different clinical entity 1

The World Health Organization recommends distinguishing isolated findings from complete pubertal development, as isolated pubic hair without breast development suggests adrenal androgen production rather than true central precocious puberty 2
The American Academy of Pediatrics suggests obtaining detailed growth velocity data, asking parents about recent acceleration in linear growth, as precocious puberty characteristically causes both accelerated growth and advanced bone maturation that ultimately compromises adult height 1, 2

The Endocrine Society recommends obtaining detailed family history of pubertal timing in parents and siblings, as familial patterns can help distinguish constitutional variants from pathologic early puberty 1
The American College of Medical Genetics and Genomics suggests asking specifically about family members with early puberty, particularly maternal age at menarche, as this provides context for genetic predisposition 1

The Centers for Disease Control and Prevention recommends systematically inquiring about potential exposure to exogenous sex steroids, including topical testosterone preparations, estrogen-containing creams, oral contraceptives, or supplements that family members may be using 1
The American Academy of Neurology suggests screening for neurological symptoms including severe headaches, visual changes, or seizures, as these are crucial red flags for CNS pathology causing central precocious puberty and mandate brain MRI 1

The National Comprehensive Cancer Network recommends reviewing history of cancer treatment, particularly chemotherapy with alkylating agents or radiotherapy potentially exposing the ovaries, as these patients require specific surveillance protocols 3, 4
The American Academy of Pediatrics suggests evaluating for behavioral problems, mood symptoms, and psychosocial adjustment, as early puberty is associated with increased risk of behavioral problems and psychological distress that may require early intervention 1, 5

The American College of Obstetricians and Gynecologists recommends ensuring Tanner staging is carefully documented during examination, as this determines whether findings represent true precocious puberty versus isolated variants like premature adrenarche 2
The Endocrine Society suggests planning for pelvic ultrasound consideration based on history findings, particularly if there are concerns for ovarian tumors, cysts, or to assess uterine size as a marker of estrogen exposure 1, 2